IMVT Straddle Strategy
IMVT (Immunovant, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
Immunovant, Inc. is a biopharmaceutical firm in the clinical development phase, dedicated to advancing novel monoclonal antibody therapies for the treatment of various autoimmune conditions. The company's primary focus is batoclimab, a pioneering, fully human monoclonal antibody. This antibody is engineered to specifically target and block the neonatal fragment crystallizable receptor (FcRn), a key mechanism in certain autoimmune diseases. Batoclimab is currently undergoing Phase IIa clinical evaluations for treating both myasthenia gravis and thyroid eye disease. Additionally, it has commenced Phase II clinical studies for patients suffering from warm autoimmune hemolytic anemia. Established in 2018, Immunovant operates from its headquarters in New York, New York, functioning as a subsidiary under the umbrella of Roivant Sciences Ltd.
IMVT (Immunovant, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $7.98B, a beta of 0.79 versus the broader market, a 52-week range of 14.32-39.28, average daily share volume of 1.9M, a public-listing history dating back to 2019, approximately 362 full-time employees. These structural characteristics shape how IMVT stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 0.79 places IMVT roughly in line with broader market moves, so the strategy payoff and realized volatility track the index-equivalent baseline.
What is a straddle on IMVT?
A long straddle buys an ATM call and an ATM put at the same strike, profiting from a large move in either direction; max loss equals the combined debit when the underlying pins to the strike at expiration.
Current IMVT snapshot
As of June 30, 2026, spot at $38.19, ATM IV 64.80%, IV rank 28.26%, expected move 18.58%. The straddle on IMVT below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 17-day expiry.
Why this straddle structure on IMVT specifically: IMVT IV at 64.80% is on the cheap side of its 1-year range, which favors premium-buying structures like a IMVT straddle, with a market-implied 1-standard-deviation move of approximately 18.58% (roughly $7.09 on the underlying). The 17-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated IMVT expiries trade a higher absolute premium for lower per-day decay. Position sizing on IMVT should anchor to the underlying notional of $38.19 per share and to the trader's directional view on IMVT stock.
IMVT straddle setup
The IMVT straddle below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With IMVT near $38.19, the first option leg uses a $38.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed IMVT chain at a 17-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 IMVT shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $38.00 | $2.58 |
| Buy 1 | Put | $38.00 | $1.93 |
IMVT straddle risk and reward
- Net Premium / Debit
- -$450.00
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- -$449.69
- Breakeven(s)
- $33.50, $42.50
- Risk / Reward Ratio
- Unbounded
Upside max profit is unbounded; downside max profit is bounded at the strike minus the combined call plus put debit (reached at zero). Max loss equals the combined debit times 100 (reached when the underlying pins to the strike). Two breakevens at strike plus debit and strike minus debit.
IMVT straddle payoff curve
Modeled P&L at expiration across a range of underlying prices for the straddle on IMVT. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
| Underlying Price | % From Spot | P&L at Expiration |
|---|---|---|
| $0.01 | -100.0% | +$3,349.00 |
| $8.45 | -77.9% | +$2,504.71 |
| $16.90 | -55.8% | +$1,660.42 |
| $25.34 | -33.7% | +$816.13 |
| $33.78 | -11.5% | -$28.17 |
| $42.22 | +10.6% | -$27.54 |
| $50.67 | +32.7% | +$816.75 |
| $59.11 | +54.8% | +$1,661.04 |
| $67.55 | +76.9% | +$2,505.33 |
| $76.00 | +99.0% | +$3,349.62 |
When traders use straddle on IMVT
Straddles on IMVT are pure-volatility plays that profit from large moves in either direction; traders typically buy IMVT straddles ahead of earnings, FDA decisions, or other catalysts where the realized move is expected to exceed the implied move priced into the chain.
IMVT thesis for this straddle
The market-implied 1-standard-deviation range for IMVT extends from approximately $31.10 on the downside to $45.28 on the upside. A IMVT long straddle is a pure-volatility play: it profits when the underlying moves far enough from the strike in either direction to overcome the combined call plus put debit, regardless of direction. Current IMVT IV rank near 28.26% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on IMVT at 64.80%. As a Healthcare name, IMVT options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to IMVT-specific events.
IMVT straddle positions are structurally neutral / high-volatility (long premium); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. IMVT positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move IMVT alongside the broader basket even when IMVT-specific fundamentals are unchanged. Always rebuild the position from current IMVT chain quotes before placing a trade.
Frequently asked questions
- What is a straddle on IMVT?
- A straddle on IMVT is the straddle strategy applied to IMVT (stock). The strategy is structurally neutral / high-volatility (long premium): A long straddle buys an ATM call and an ATM put at the same strike, profiting from a large move in either direction; max loss equals the combined debit when the underlying pins to the strike at expiration. With IMVT stock trading near $38.19, the strikes shown on this page are snapped to the nearest listed IMVT chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are IMVT straddle max profit and max loss calculated?
- Upside max profit is unbounded; downside max profit is bounded at the strike minus the combined call plus put debit (reached at zero). Max loss equals the combined debit times 100 (reached when the underlying pins to the strike). Two breakevens at strike plus debit and strike minus debit. For the IMVT straddle priced from the end-of-day chain at a 30-day expiry (ATM IV 64.80%), the computed maximum profit is unbounded per contract and the computed maximum loss is -$449.69 per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a IMVT straddle?
- The breakeven for the IMVT straddle priced on this page is roughly $33.50 and $42.50 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current IMVT market-implied 1-standard-deviation expected move is approximately 18.58%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a straddle on IMVT?
- Straddles on IMVT are pure-volatility plays that profit from large moves in either direction; traders typically buy IMVT straddles ahead of earnings, FDA decisions, or other catalysts where the realized move is expected to exceed the implied move priced into the chain.
- How does current IMVT implied volatility affect this straddle?
- IMVT ATM IV is at 64.80% with IV rank near 28.26%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.